Key result
Non-invasive techniques for assessing myocardial viability have technical limitations, and quantifying viable myocardium alone is insufficient to predict clinical benefit after revascularisation.
Design
Review
Authors
Loading...
Viability quantification alone should not guide revascularization decisions; leaves open the need for integrated predictive models in future studies.
The authors propose that simply quantifying the amount of viable myocardium using non-invasive imaging is insufficient to comprehensively predict functional improvement or clinical benefit after coronary revascularization.
R. J. Kim (2004) conducted a review in Ischaemic heart disease. Non-invasive myocardial viability assessment (SPECT, DSE, PET) was evaluated. Non-invasive techniques for assessing myocardial viability have technical limitations, and quantifying viable myocardium alone is insufficient to predict clinical benefit after revascularisation.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: